Tonix Pharmaceuticals Holding (TNXP) Cash from Investing Activities (2011 - 2026)
Tonix Pharmaceuticals Holding (TNXP) posted quarterly Cash from Investing Activities of -$1.7 million for Q1 2026, down 28100.0% year-over-year from N/an in Q1 2025, and down 65.72% quarter-over-quarter from -$1.0 million in Q4 2025.
Tonix Pharmaceuticals Holding (TNXP) Cash from Investing Activities (2011 - 2026) Analysis & Trends
Tonix Pharmaceuticals Holding's Cash from Investing Activities history runs 16 years deep, the most recent figure standing at -$1.7 million for Q1 2026.
- In Q1 2026, Cash from Investing Activities fell 28100.0% year-over-year to -$1.7 million; the TTM figure through Mar 2026 stood at -$6.2 million (down 34422.22% YoY), while the FY2025 annual figure was -$4.5 million, down 3673.33% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$1.7 million, down from -$1.0 million in the prior quarter.
- The five-year high for Cash from Investing Activities was -$3000.0 in Q4 2024, with the low at -$24.0 million in Q2 2023.
- The 5-year median for Cash from Investing Activities is -$1.4 million (2025), against an average of -$5.2 million.
- The sharpest annual moves came in 2024 and 2025: Cash from Investing Activities jumped 99.3% in 2024, then plunged 33933.33% in 2025.
- Tonix Pharmaceuticals Holding's Cash from Investing Activities stood at -$4.7 million in 2022, then soared by 90.77% to -$431000.0 in 2023, then surged by 99.3% to -$3000.0 in 2024, then slumped by 33933.33% to -$1.0 million in 2025, then sank by 65.72% to -$1.7 million in 2026.
- Business Quant data shows TNXP's Cash from Investing Activities at -$1.7 million in Q1 2026, -$1.0 million in Q4 2025, and -$962000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -45.80 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -92.70 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -1.66 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -49.35 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 19.77 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -229.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -363.46 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 24.51 Mn |
| 10 | Tonix Pharmaceuticals Holding | 213.43 Mn | 213.43 Mn | 12.84 Mn | -587,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -587,000.00 |
| Jun 30, 2026 | -587,000.00 |
| Mar 31, 2026 | -1.69 Mn |
| Mar 31, 2026 | -1.69 Mn |
| Dec 31, 2025 | -1.02 Mn |
| Dec 31, 2025 | -1.02 Mn |
| Sep 30, 2025 | -962,000.00 |
| Sep 30, 2025 | -962,000.00 |
| Jun 30, 2025 | -2.54 Mn |
| Jun 30, 2025 | -2.54 Mn |
| Mar 31, 2025 | -6,000.00 |
| Mar 31, 2025 | -6,000.00 |
| Dec 31, 2024 | -3,000.00 |
| Dec 31, 2024 | -3,000.00 |
| Sep 30, 2024 | -9,000.00 |
| Sep 30, 2024 | -9,000.00 |
| Mar 31, 2024 | -108,000.00 |
| Mar 31, 2024 | -108,000.00 |
| Dec 31, 2023 | -431,000.00 |
| Dec 31, 2023 | -431,000.00 |